Dr. Abidi Pharmaceutical Laboratories (DABID) income statement
Operating revenue through to net profit and earnings per share
Fundamental analysis of DABID on Fundai: DABID Fundamental Analysis, Mehr 1405: Profit Forecast and Valuation
- Ticker
- DABID
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 243,313,740 | 95,896,355 | 58,912,406 | 46,549,776 | 27,904,566 | 15,925,840 |
| Cost of operating revenue | -93,871,091 | -39,817,908 | -25,670,742 | -17,226,599 | -10,912,228 | -6,441,067 |
| Gross profit (loss) | 149,442,649 | 56,078,447 | 33,241,664 | 29,323,177 | 16,992,338 | 9,484,773 |
| Selling, general and administrative expenses | -30,120,350 | -15,224,142 | -10,251,637 | -7,009,687 | -4,125,545 | -2,465,947 |
| Other income | 543,561 | 273,298 | 105,183 | 264,330 | 125,713 | 71,009 |
| Other expenses | -231,509 | -827,982 | -111,971 | -62,935 | -6,988 | -17,630 |
| Operating profit (loss) | 119,634,351 | 40,299,621 | 22,983,239 | 22,514,885 | 12,985,518 | 7,072,205 |
| Finance costs | -23,706,633 | -9,863,661 | -10,449,433 | -3,511,445 | -3,005,326 | -1,655,599 |
| Other non-operating income and expenses | 10,331,595 | 443,298 | 114,897 | 180,854 | 189,865 | 82,758 |
| Profit (loss) from continuing operations before tax | 106,259,313 | 30,879,258 | 12,648,703 | 19,184,294 | 10,170,057 | 5,499,364 |
| Current year tax | -17,001,490 | -6,484,644 | -2,647,604 | -4,028,702 | -2,186,562 | -1,347,344 |
| Net profit (loss) from continuing operations | 89,257,823 | 24,394,614 | 10,001,099 | 15,155,592 | 7,983,495 | 4,152,020 |
| Net profit (loss) | 89,257,823 | 24,394,614 | 10,001,099 | 15,155,592 | 7,983,495 | 4,152,020 |
| Basic earnings (loss) per share | 1,594 rials | 595 rials | 400 rials | 606 rials | 1,774 rials | 923 rials |
| Net earnings (loss) per share, rials | 1,594 rials | 595 rials | 401 rials | 607 rials | 592 rials | 923 rials |
| Capital | 56,000,000 | 41,000,000 | 25,000,000 | 25,000,000 | 13,500,000 | 4,500,000 |
Reporting periods
90 periods are on file for this report, from the period ending 1380/12/29 to the period ending 1405/06/31.